Though our analysis focused primarily on LEF1 and SPP1, other highly-ranked signature genes with increased expression in CLM compared to primary CRC also have biological functions consistent with roles in tumor progression, and might have prognostic utility. This evidence concerns the gene LEF1 and colorectal carcinoma.